The Endometrial Immune Profiling May Positively Affect the Management of Recurrent Pregnancy Loss
- PMID: 33841443
- PMCID: PMC8024694
- DOI: 10.3389/fimmu.2021.656701
The Endometrial Immune Profiling May Positively Affect the Management of Recurrent Pregnancy Loss
Abstract
Introduction: The endometrial immune profiling is an innovative approach based on the analysis of the local immune reaction occurring in the endometrium at the time of the embryo implantation. By documenting the local immune activation during the period of uterine receptivity, we aim to detect and correct potential imbalances before and at the very beginning of placentation. The main objective of the study was to analyze in women with a history of repeated pregnancy loss (RPL) the association of personalized strategies based on immune dysregulations with live birth rates. The secondary objective was to highlight the main prognostic factors for live births.
Methods: This is an observational retrospective analysis of 104 patients with RPL, included between January 2012 and December 2019. Inclusion criteria included a spontaneous fertility with at least three miscarriages, an assessment including a three-dimension ultrasound scan, an endometrial biopsy for uterine immune profiling and a follow-up over at least 6 months with personalized care if indicated after the complete assessment. We defined as a success if the patients had a live birth after the suggested plan, as a failure if the patient either did not get pregnant or experienced a new miscarriage after the targeted therapies.
Results: Uterine immune profiling was the only exploration to be significantly associated with a higher live birth rate (LBR) if a dysregulation was identified and treated accordingly (55% vs 45%, p=0.01). On the contrary, an absence of local dysregulation (resulting in an apparently balanced immune environment) was associated with a higher risk of a new miscarriage, suggesting that the cause inducing RPL still needed to be identified. Independently of age and AMH level, dysregulated immune profile is significatively associated with 3 times higher LBR than a non-deregulated profile (OR=3.4 CI 95%1.27-9.84) or five times in case of an overactive profile treated by immunotherapy (OR=5 CI 95% 1.65-16.5). The usage of ART was significantly associated with lower LBR regardless of the presence of a subfertility factor (p=0.012). Personalization of medical care using natural cycle or simple hormonal stimulation is associated with a significantly higher LBR than personalization including ART treatments regardless of maternal age and AMH level (OR= 2.9 CI 95% 1.03-8.88).
Conclusion: Our study suggests that some endometrial immune profiles with targeted management of RPL are associated with a higher rate of LBR. ART may be negatively associated with LBR.
Keywords: Assisted Reproductive Technology (ART); embryo implantation; endometrium; recurrent pregnancy loss (RPL); uterine immune profile.
Copyright © 2021 Cheloufi, Kazhalawi, Pinton, Rahmati, Chevrier, Prat-ellenberg, Michel, Dray, Mekinian, Kayem and Lédée.
Conflict of interest statement
NL created the MatriceLAB Innove SARL company and holds a patent covering the endometrial immune assessment test and appended recommendations (PCT/EP2013/065355). Authors AK and LC were also employed by MatriceLAB Innove SARL. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.Hum Reprod. 2021 Mar 18;36(4):929-940. doi: 10.1093/humrep/deab014. Hum Reprod. 2021. PMID: 33608730
-
Endometrial Immune Profiling: A Method to Design Personalized Care in Assisted Reproductive Medicine.Front Immunol. 2020 Jun 4;11:1032. doi: 10.3389/fimmu.2020.01032. eCollection 2020. Front Immunol. 2020. PMID: 32582163 Free PMC article.
-
Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies.Cochrane Database Syst Rev. 2017 May 23;5(5):CD011872. doi: 10.1002/14651858.CD011872.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Mar 16;3:CD011872. doi: 10.1002/14651858.CD011872.pub3. PMID: 28534597 Free PMC article. Updated. Review.
-
Uterine immune profiling for increasing live birth rate: A one-to-one matched cohort study.J Reprod Immunol. 2017 Feb;119:23-30. doi: 10.1016/j.jri.2016.11.007. Epub 2016 Nov 24. J Reprod Immunol. 2017. PMID: 27915039
-
Endometrial injury in women undergoing assisted reproductive techniques.Cochrane Database Syst Rev. 2015 Mar 22;(3):CD009517. doi: 10.1002/14651858.CD009517.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Jun 10;6:CD009517. doi: 10.1002/14651858.CD009517.pub4. PMID: 25803542 Updated. Review.
Cited by
-
The Next Frontier in ART: Harnessing the Uterine Immune Profile for Improved Performance.Int J Mol Sci. 2023 Jul 11;24(14):11322. doi: 10.3390/ijms241411322. Int J Mol Sci. 2023. PMID: 37511080 Free PMC article. Review.
-
Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning.Front Immunol. 2022 Sep 5;13:952708. doi: 10.3389/fimmu.2022.952708. eCollection 2022. Front Immunol. 2022. PMID: 36131919 Free PMC article.
-
Glucocorticoid therapy in assisted reproduction.Clin Exp Reprod Med. 2021 Dec;48(4):295-302. doi: 10.5653/cerm.2021.04819. Epub 2021 Nov 30. Clin Exp Reprod Med. 2021. PMID: 34875736 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical